Skip to main content

Year: 2020

XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement

EMERYVILLE, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has earned a $1 million milestone payment from Agenus Inc. (NASDAQ: AGEN) related to Merck’s advancement of MK-4830 into a Phase 2 study in patients with advanced non-small cell lung cancer (NSCLC) previously treated with anti-programmed cell death receptor ligand 1 (PD-L1) therapy.  MK-4830 is part of XOMA’s first transaction under its royalty and milestone aggregator business model in which the Company acquired a royalty interest in seven milestone and royalty-bearing licenses Agenus held with Merck and Incyte for $15 million.“Today’s announcement marks the first asset that the XOMA team acquired under our royalty and milestone aggregator business model to achieve a clinical milestone.  We congratulate...

Continue reading

Beyond Air® Submits Premarket Approval Application to FDA for LungFit™ PH to Treat Persistent Pulmonary Hypertension of the Newborn

Potential to revolutionize nitric oxide therapy by eliminating need for cumbersome cylinders creating improved economics and safety in hospital settingWill be subject to a 180-day review period by the FDALaunch expected in 2Q 2021, pending approvalGARDEN CITY, N.Y., Nov. 11, 2020 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors, today announced the submission of a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its LungFit™ PH to treat persistent pulmonary hypertension of the newborn (PPHN). FDA guidelines...

Continue reading

Want An Absolutely Cool T-Shirt? Check Out ADM Endeavors, Inc. (ADMQ)

FORT WORTH, Texas, Nov. 11, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — We all love T-Shirts with cool designs. ADM Endeavors, Inc. (OTCQB: ADMQ) is pleased to announce that its wholly owned subsidiary, FW Promo, has posted numerous ideas to make your T-shirt the talk of your school, your community, and your family.Visit:  https://www.fwpromo.com/t-shirt-design-ideas/.Ideas include: Repeating text:  Take a phrase or a word and repeat it in different patterns or colors.  This really will bring attention to your message.Handwritten typography:  Scripted word, with thousands of fonts to choose from, are very trendy.  Add design flourishes.Retro:  Use design elements or type to recall previous epic times. Off Register:  A fun new trend.  Color outside the lines to attract the eye to elements within your design.Holidays:  Fun upcoming...

Continue reading

Intellia Therapeutics Receives Grant to Develop Curative CRISPR/Cas9 In Vivo Sickle Cell Disease Treatments

Funding from the Bill & Melinda Gates Foundation to develop safe, scalable and accessible non-viral treatments for sickle cell patientsCAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), announced that it has received a grant from the Bill & Melinda Gates Foundation to research in vivo sickle cell disease (SCD) treatments using its CRISPR/Cas9 genome editing technology. This pilot development program is part of the Gates Foundation’s broader initiative to accelerate the advancement of safe, effective and durable gene-based cures in developing countries within the next seven to 10 years. The funding from the Gates Foundation will advance Intellia’s preclinical validation of in vivo hematopoietic stem cells (HSCs) genome editing using the company’s proprietary non-viral delivery...

Continue reading

MasterCraft Boat Holdings, Inc. Reports Record Earnings for Fiscal 2021 First Quarter

VONORE, Tenn., Nov. 11, 2020 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2021 first quarter ended October 4, 2020.Highlights:Most profitable first quarter in the Company’s historyPurchase of Merritt Island, Florida facility completed on October 26, 2020, increasing production capacity for the MasterCraft and Aviara brandsNet sales for the first quarter decreased to $103.7 million, down 5.5 percent from $109.8 million in the prior-year periodNet income was $9.6 million or $0.51 per diluted share, a 10.9 percent increase from $0.46 in the prior-year periodDiluted Adjusted Net Income per share, a non-GAAP measure, was $0.58, a 7.4 percent increase from $0.54 in the prior-year periodAdjusted EBITDA, a non-GAAP measure, grew 6.8 percent to $17.0 million from $15.9...

Continue reading

Canadian Electricity Association Chooses NexTech AR’s InfernoAR Platform to Host 2020 Virtual Powering Partnerships Summit

VANCOUVER, British Columbia, Nov. 11, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality for eCommerce, AR learning applications, AR-enhanced video conferencing and virtual events today announced that the Canadian Electricity Association (CEA) has chosen its InfernoAR platform to transform its annual Powering Partnerships Summit, taking place November 23-26, 2020, into a completely virtual collaborative experience. The company continues to expand both its technology offerings and its global footprint for virtual experiences as the digital transformation accelerates.During this annual summit, CEA brings together electricity sector CEOs and C-level representatives from across Canada, council and committee chairs, corporate partners, and elected officials....

Continue reading

Canacol Energy Ltd. Announces Director Oswaldo Cisneros Has Passed Away

CALGARY, Alberta, Nov. 11, 2020 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) regrets to announce that Mr. Oswaldo Cisneros, non‐executive director of Canacol since 2015, has passed away. Mr. Charle Gamba, President, CEO and Executive Board Member for Canacol, stated, “The Board of Directors, the executive management team, and the employees of Canacol express their sincere condolences to Mr. Cisneros’ family during this difficult time. Mr. Cisneros’ support and guidance with respect to the transformation of Canacol was crucial to our success, and his advice, common sense, and presence will be greatly missed.”Canacol Energy Ltd. is a gas exploration and production company with operations focused in Colombia. The Corporation’s...

Continue reading

Cann-Is Capital Corp. Provides Update on Qualifying Transaction with CWE European Holdings Inc.

TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) — Cann-Is Capital Corp. (“Cann-Is” or the “Corporation”) (TSX-V: NIS.P) is pleased to provide certain updates from its press release dated September 23, 2020 in regards to the Corporation’s proposed qualifying transaction (the “Transaction”) with CWE European Holdings Inc., a company incorporated under the laws of the Province of Alberta (“CWE”), pursuant to which the Corporation will acquire all of the issued and outstanding shares in the capital of CWE. When completed, the Transaction will constitute the Corporation’s Qualifying Transaction, as such term is defined in the policies of the TSX Venture Exchange (the “Exchange”). The Transaction is subject to compliance with all necessary regulatory and other approvals and certain other terms and conditions. The parties executed a binding...

Continue reading

Point-of-Care Industry Expert, Angelo Campano, Joins OptimizeRx Executive Leadership as Senior Vice President and Principal of Agency Channels

ROCHESTER, Mich., Nov. 11, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has appointed Angelo Campano to the new position of senior vice president and principal of agency channels.Campano will be responsible for driving the strategic growth and expansion of OptimizeRx partnerships with healthcare advertising agencies. This includes implementing point-of-care engagement programs designed for specific populations of patients and providers.“Angelo is an incredibly well-respected thought leader, innovator and strategist in point-of-care solutions, and we are honored to have him join our team,” said Steve Silvestro, chief commercial officer at OptimizeRx. “His proven ability to develop partnerships that bring digital touchpoints...

Continue reading

Kitov Pharma to Participate in November Investor Conferences

TEL AVIV, Israel, Nov. 11, 2020 (GLOBE NEWSWIRE) — Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that management will present at the H.C. Wainwright 6th Annual Israel Conference and will participate in one-on-one meetings at the Jefferies Virtual London Healthcare Conference.H.C. Wainwright 6th Annual Israel Conference                Date:                 Thursday, November 12, 2020            Time:                9:00 am Eastern TimeTo view the live presentation, please register for the conference: www.hcwevents.com/israel.            Jefferies Virtual London Healthcare Conference        Date:                Tuesday, November 17, 2020 – Thursday, November 19, 2020About Kitov PharmaKitov Pharma Ltd....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.